tiprankstipranks
BLUE Earnings this Week: How Will it Perform?
PremiumPre-EarningsBLUE Earnings this Week: How Will it Perform?
25d ago
Class Action Lawsuit against Bluebird Bio, Inc. (NASDAQ:BLUE)
PremiumMarket News
Class Action Lawsuit against Bluebird Bio, Inc. (NASDAQ:BLUE)
25d ago
Bluebird Bio completes commercial cell collection for LYFGENIA
PremiumThe Fly
Bluebird Bio completes commercial cell collection for LYFGENIA
26d ago
bluebird bio, Inc. Class Action: Levi & Korsinsky LLP Reminds bluebird bio Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 28, 2024 – BLUE
PremiumClass Actionbluebird bio, Inc. Class Action: Levi & Korsinsky LLP Reminds bluebird bio Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 28, 2024 – BLUE
2M ago
Bluebird Bio price target lowered to $4 from $5 at BofA
PremiumThe Fly
Bluebird Bio price target lowered to $4 from $5 at BofA
2M ago
Bluebird Bio price target lowered to $3 from $4 at Wells Fargo
PremiumThe Fly
Bluebird Bio price target lowered to $3 from $4 at Wells Fargo
2M ago
Cantor Fitzgerald biotech analysts hold an analyst/industry conference call
PremiumThe FlyCantor Fitzgerald biotech analysts hold an analyst/industry conference call
3M ago
Bluebird Bio signs Medicaid outcomes-based agreement for Lyfgenia
PremiumThe Fly
Bluebird Bio signs Medicaid outcomes-based agreement for Lyfgenia
3M ago
Bluebird Bio provides update on commercial launch, announces factoring deal
PremiumThe Fly
Bluebird Bio provides update on commercial launch, announces factoring deal
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100